You Searched For "pfizer biontech" and got 20 results
Sort By:
2 mins read
Pfizer and BioNTech surge after the FDA officially approves its COVID-19 vaccine
The vaccine will be marketed under the brand name Comirnaty, and the FDA hopes the approval will nu…
Matthew Fox
3 mins read
Pfizer and AstraZeneca COVID-19 vaccines less effective against Delta variant, says a Oxford University study
Two doses of either vaccine still provided at least the same level of protection as having had …
PTI
1 min read
Pfizer and BioNTech have started testing an Omicron-specific COVID-19 vaccine for adults
The study will measure the safety and effectiveness of a vaccine tailored to the Omicron variant in…
Jake Epstein
2 mins read
Pfizer, BioNTech ask FDA to authorize two-dose COVID-19 vaccine for children under 5
In a Tuesday press release, the FDA said the agency pushed Pfizer and BioNTech to submit the applic…
Erin Snodgrass
2 mins read
BioNTech has already started developing a new Omicron version of its COVID-19 vaccine
The German biotech, which makes COVID-19 vaccines with Pfizer, said Monday it doesn't want to "wast…
Mary Hanbury
1 min read
Pfizer soars 11% on strong results from COVID-19 pill study, while Moderna and Merck tumble
Pfizer plans to seek the Food and Drug Administration's OK this month for the pill, with doses pote…
Phil Rosen
3 mins read
The FDA's expert panel just gave a thumbs-up for Pfizer's COVID-19 vaccine in younger children, clearing the path for authorization in a matter of days
Younger children between 5 and 11 years old could start getting the Pfizer-BioNTech coronavirus vac…
Andrew Dunn
2 mins read
The FDA is weighing in on whether to authorize Pfizer's COVID-19 vaccine in younger kids
The data comes as the Food and Drug Administration enters the final stages of reviewing Pfizer's ap…
Andrew Dunn
4 mins read
FDA authorizes boosters of the Pfizer-BioNTech coronavirus vaccine for older adults and others at high risk from COVID-19
The hope is that booster shots will help protect those most at risk as the pandemic continues to ra…
Andrew Dunn
2 mins read
Pfizer climbs after boosting its 2021 COVID-19 vaccine sales forecast by 73%
The company now expects vaccine revenues of around $26 billion, 73% higher than initially projected.
Isabelle Lee
2 mins read
The Pfizer vaccine's full name is Comirnaty - a hectic mashup of COVID-19, community, immunity, and mRNA
Pfizer's COVID-19 vaccine got full FDA approval on Monday, including of its official name, Comirnat…
Dr. Catherine Schuster-Bruce
1 min read
Moderna and BioNTech stocks are surging amid reports of FDA vaccine-approval progress
Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headl…
Ethan Wu
2 mins read
Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval
The companies aim to apply for emergency-use authorization within days. If approved, the vaccine co…
Ben Winck
2 mins read
Moderna was the most-bought stock for retail traders in the week leading up to its 16% single-day plunge
Wall Street analysts appear less keen than retail traders on vaccine makers such as Moderna, after …
Harry Robertson
2 mins read
Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects
The EU's drug regulator is looking at reports about skin rash and kidney problems.
Carla Mozée
1 min read
BioNTech rallies 16% after boosting the sales forecast for its COVID-19 vaccine and projecting sturdy demand ahead
Vaccine demand is likely to persist well into next year, the company said, with more than a billion…
Ethan Wu
1 min read
FDA expected to approve Pfizer-BioNTech's COVID-19 vaccine by early September: NYT
The pharmaceutical company filed its application with the FDA on May 7, and the FDA is expected to …
Azmi Haroun
2 mins read
Canada approves Pfizer-BioNTech COVID-19 vaccine for 12-15 year olds
Canada announced its approval of administering the Pfizer-BioNTech Covid-19 vaccine to children age…
2 mins read
Israel will roll out a booster dose of the Pfizer-BioNTech COVID-19 vaccine to older people, citing a drop in protection against severe disease driven by the Delta variant
Israeli health officials said they'd seen protection against severe illness from Pfizer's vaccine d…
Andrew Dunn
3 mins read
8 weeks between shots is the 'sweet spot' for giving Pfizer's two-dose COVID-19 vaccine, UK researchers say
It's not yet clear how changes in immune response relate to the protection you get from Pfizer's CO…